Basic Fibroblast Growth Factor Stimulation of Glial Cells Protects Dopamine Neurons from 6‐Hydroxydopamine Toxicity: Involvement of the Glutathione System

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Neurochemistry

• Publication date

  1997-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1046/j.1471-4159.1997.69010076.xPMID 9202296
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The presence of glutathione in primary neuronal and astroglial cultures from rat cerebral cortex and brain stem

  2005cited by this paper
• Glial Cell Line‐Derived Neurotrophic Factor Exerts Neurotrophic Effects on Dopaminergic Neurons In Vitro and Promotes Their Survival and Regrowth After Damage by 1‐Methyl‐4‐Phenylpyridinium

  1996cited by this paper
• Glutathione Efflux from Cultured Astrocytes

  1996cited by this paper
• l‐DOPA Up‐Regulates Glutathione and Protects Mesencephalic Cultures Against Oxidative Stress

  1996cited by this paper
• Neurotrophic Factors Attenuate Glutamate‐Induced Accumulation of Peroxides, Elevation of Intracellular Ca2+ Concentration, and Neurotoxicity and Increase Antioxidant Enzyme Activities in Hippocampal Neurons

  1995cited by this paper
• Role of mitochondria in the etiology and pathogenesis of Parkinson's disease.

  1995cited by this paper
• Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

  1995cited by this paper
• Free Radical‐Generated Neurotoxicity of 6‐Hydroxydopamine

  1995cited by this paper
• Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

  1995cited by this paper
• Vitamin E, Ascorbate, Glutathione, Glutathicne Disulfide, and Enzymes of Glutathione Metabolism in Cultures of Chick Astrocytes and Neurons: Evidence that Astrocytes Play an Important Role in Antioxidative Processes in the Brain

  1994cited by this paper
• Purification and Initial Characterization of Rat B49 Glial Cell Line‐Derived Neurotrophic Factor

  1994cited by this paper
• Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

  1994cited by this paper
• Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo

  1994cited by this paper
• Effects of nerve growth factor on catalase and glutathione peroxidase in a hydrogen peroxide-resistant pheochromocytoma subclone.

  1994cited by this paper
• Damage to Neurons in Culture Following Medium Change: Role of Glutamine and Extracellular Generation of Glutamate

  1993cited by this paper
• GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.

  1993cited by this paper
• Cystine Uptake and Glutathione Level in Fetal Brain Cells in Primary Culture and in Suspension

  1993cited by this paper
• Maintenance of Neuronal Glutathione by Glial Cells

  1993cited by this paper
• Toxic and Protective Effects of l‐DOPA on Mesencephalic Cell Cultures

  1993cited by this paper
• A radical hypothesis for neurodegeneration.

  1993cited by this paper
• The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it

  1992cited by this paper
• Glutathione in Parkinson's disease: A link between oxidative stress and mitochondrial damage?

  1992cited by this paper
• Brain‐Derived Neurotrophic Factor Protects Dopamine Neurons Against 6‐Hydroxydopamine and N‐Methyl‐4‐Phenylpyridinium Ion Toxicity: Involvement of the Glutathione System

  1992cited by this paper
• Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.

  1992cited by this paper
• Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study.

  1992cited by this paper
• The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia [published erratum appears in J Neurosci 1992 Mar;12(3):685]

  1991cited by this paper
• Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

  1991cited by this paper
• Insulin-like growth factors I and II.

  1990cited by this paper
• Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II

  1990cited by this paper
• Role of nerve growth factor in oxidant‐antioxidant balance and neuronal injury. I. Stimulation of hydrogen peroxide resistance

  1990cited by this paper
• Mitochondrial Complex I Deficiency in Parkinson's Disease

  1989cited by this paper
• Intracerebroventricular Administration of l‐Buthionine Sulfoximine: A Method for Depleting Brain Glutathione

  1989cited by this paper
• Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

  1989cited by this paper
• Mitochondrial complex I deficiency in Parkinson's disease.

  1989cited by this paper
• Reduction of Brain Glutathione by l‐Buthionine Sulfoximine Potentiates the Dopamine‐Depleting Action of 6‐Hydroxydopamine in Rat Striatum

  1989cited by this paper
• Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture.

  1989cited by this paper
• Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

  1989cited by this paper
• Depletion of Brain Glutathione in Preweanling Mice by L‐Buthionine Sulfoximine

  1988cited by this paper
• Histochemical evaluation of glutathione in brain.

  1987cited by this paper
• Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).

  1979cited by this paper
• Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro.

  1978cited by this paper
• Mechanisms of action of 6-hydroxydopamine.

  1975cited by this paper
• The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents.

  1974cited by this paper
• Further studies on the generation of hydrogen peroxide by 6-hydroxydopamine. Potentiation by ascorbic acid.

  1972cited by this paper
• Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues.

  1969cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Glutaminergic Modulators as Potential Therapeutic Modalities for Neuropathic Pain.

  2025cites this paper
• Fumaria vaillantii extract protects PC12 cells against neurotoxicity induced by 6-OHDA

  2024cites this paper
• The Effects of FGF2 Application on Oxidative Status of Wound Tissue in Normo- and Hyperglycemic Rats: A Time-Based Study

  2022cites this paper
• Physical Exercise-Induced Myokines in Neurodegenerative Diseases

  2021cites this paper
• Neuron-Astrocyte Interactions in Parkinson’s Disease

  2020cites this paper
• PHYSICAL ACTIVITY–INDUCED NEUROPROTECTION IN PARKINSON’S DISEASE IS MEDIATED BY NEUROTROPHIC FACTORS

  2020cites this paper
• Human Basic Fibroblast Growth Factor Inhibits Tau Phosphorylation via the PI3K/Akt-GSK3β Signaling Pathway in a 6-Hydroxydopamine-Induced Model of Parkinson's Disease

  2016cites this paper
• The Mechanisms Underlying Cocaine-Induced Overexpression of Basic Fibroblast Growth Factor (bFGF, FGF2), an Effect Reversed By Extinction

  2016cites this paper
• Dichlorodiphenyldichloroethylene exposure reduces r‐GCS via suppressed Nrf2 in HepG2 cells

  2016cites this paper
• Protection of cultured dopamine neurons from MPP+ requires a combination of neurotrophic factors

  2016cites this paper
• Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease

  2016cites this paper
• Neuroprotective potential of AAV-mediated NURR1 expression in a rat model of Parkinson’s disease

  2015cites this paper
• Blocking Infralimbic Basic Fibroblast Growth Factor (bFGF or FGF2) Facilitates Extinction of Drug Seeking After Cocaine Self-Administration

  2015cites this paper
• Redox status in mammalian cells and stem cells during culture in vitro: Critical roles of Nrf2 and cystine transporter activity in the maintenance of redox balance

  2014cites this paper
• Role of ERK1, 2, and 5 in dopamine neuron survival during aging.

  2014cites this paper
• Glial-Neuronal Interactions during Oxidative Stress Implications for Parkinson’s Disease

  2013cites this paper
• Doxycycline restrains glia and confers neuroprotection in a 6‐OHDA Parkinson model

  2013cites this paper
• Neuroprotective effects of luteolin against apoptosis induced by 6-hydroxydopamine on rat pheochromocytoma PC12 cells

  2013cites this paper
• SF-6 attenuates 6-hydroxydopamine-induced neurotoxicity: an in vitro and in vivo investigation in experimental models of Parkinson's disease.

  2012cites this paper
• Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

  2012cites this paper
• Motoneurons Secrete Angiogenin to Induce RNA Cleavage in Astroglia

  2012cites this paper
• Chronic lead intoxication affects glial and neural systems and induces hypoactivity in adult rat.

  2011cites this paper
• Mutations in PNKD causing paroxysmal dyskinesia alters protein cleavage and stability

  2011cites this paper
• The neurochemical consequences of aromatic L-amino acid decarboxylase deficiency

  2011cites this paper
• Fibroblast growth factor 9 upregulates heme oxygenase-1 and gamma-glutamylcysteine synthetase expression to protect neurons from 1-methyl-4-phenylpyridinium toxicity.

  2010cites this paper
• Mesenchymal stem cells inhibition of chronic ethanol-induced oxidative damage via upregulation of phosphatidylinositol-3-kinase/Akt and modulation of extracellular signal-regulated kinase 1/2 activation in PC12 cells and neurons.

  2010cites this paper
• NERVTILLVÄXTFAKTORERNAS OCH GLIACELLERNAS ROLL I

  2010cites this paper
• Fibroblast growth factor 9 prevents MPP+‐induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro

  2009cites this paper
• The putative neuroprotective role of dopamine agonists in parkinson’s disease

  2009cites this paper
• Endogenous Defenses that Protect Dopamine Neurons

  2008cites this paper
• Stress and cocaine interact to modulate basic fibroblast growth factor (FGF-2) expression in rat brain

  2008cites this paper
• Synergistic neuroprotective effect via simian lentiviral vector‐mediated simultaneous gene transfer of human pigment epithelium‐derived factor and human fibroblast growth factor‐2 in rodent models of retinitis pigmentosa

  2008cites this paper
• Quantitative evaluation of chaperone activity and neuroprotection by different preparations of a cell-penetrating Hsp70.

  2008cites this paper
• Antioxidant Enzymatic System in Neuronal and Glial Cells Enriched Fractions of Rat Brain After Aluminum Exposure

  2007cites this paper
• Amphetamine induces dendritic growth in ventral tegmental area dopaminergic neurons in vivo via basic fibroblast growth factor.

  2006cites this paper
• Dynamic regulation of fibroblast growth factor 2 (FGF‐2) gene expression in the rat brain following single and repeated cocaine administration

  2006cites this paper
• Adult rat bone marrow stromal cells express genes associated with dopamine neurons.

  2006cites this paper
• Impact of basic FGF expression in astrocytes on dopamine neuron synaptic function and development

  2006cites this paper
• Lentivirus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease.

  2006cites this paper
• New Therapeutic Approaches to Parkinson’s Disease Including Neural Transplants

  2005cites this paper
• Baicalein prevents 6-hydroxydopamine-induced dopaminergic dysfunction and lipid peroxidation in mice.

  2005cites this paper
• The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease.

  2004cites this paper
• Role of Hydrogen Peroxide in the Aetiology of Alzheimer’s Disease

  2004cites this paper
• Effects of 6‐hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line‐derived neurotrophic factor

  2004cites this paper
• Differential effects of carboxyfullerene on MPP+/MPTP-induced neurotoxicity.

  2004cites this paper
• Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease

  2004cites this paper
• Neurotrophic and neuroprotective effects of the neuregulin glial growth factor‐2 on dopaminergic neurons in rat primary midbrain cultures

  2004cites this paper
• Effects of sex and hormonal status on astrocytic basic fibroblast growth factor-2 and tyrosine hydroxylase immunoreactivity after medial forebrain bundle 6-hydroxydopamine lesions of the midbrain dopamine neurons.

  2003cites this paper
• Intranigral infusion of interleukin‐1β activates astrocytes and protects from subsequent 6‐hydroxydopamine neurotoxicity

  2003cites this paper
• Differential activation of astrocytes and microglia during post-natal development of dopaminergic neuronal death in the weaver mouse.

  2003cites this paper
• The role of metallothionein II in neuronal differentiation and survival.

  2003cites this paper
• Lipopolysaccharide prevents cell death caused by glutathione depletion: possible mechanisms of protection.

  2002cites this paper
• Fibroblast growth factors and neuroprotection.

  2002cites this paper
• Evaluation of the protective effect of oestradiol against toxicity induced by 6‐hydroxydopamine and 1‐methyl‐4‐phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture

  2002cites this paper
• Astrocytic basic fibroblast growth factor expression in dopaminergic regions after perinatal anoxia.

  2002cites this paper
• Melatonin reverses neurochemical alterations induced by 6-OHDA in rat striatum.

  2002cites this paper
• Glial-Neuronal Interactions during Oxidative Stress

  2002cites this paper
• Induction of FGF as a mechanism of acquired anticancer drug resistance

  2002cites this paper
• Prospects for the treatment of Parkinson’s disease using neurotrophic factors

  2001cites this paper
• Strain-Dependen tSusceptibilit yto MPT Pan dMPP 1 -Induced Parkinsonis mI sDetermine db yGlia

  2001cites this paper
• Neurotrophic and neurotoxic effects of nitric oxide on fetal midbrain cultures

  2001cites this paper
• Strain‐dependent susceptibility to MPTP and MPP+‐induced Parkinsonism is determined by glia

  2001cites this paper
• Role of Free Radicals in the Neurodegenerative Diseases

  2001cites this paper
• Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra.

  2001cites this paper
• The Role of Neurotrophic Factors in Psychostimulant-induced Behavioral and Neuronal Plasticity

  2001cites this paper
• Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents.

  2001cites this paper
• Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra.

  2001cites this paper
• Melatonin protects against 6‐OHDA‐induced neurotoxicity in rats: a role for mitochondrial complex I activity

  2001cites this paper
• Adaptative responses of spinal astrocytes to oxidative stress.

  2001cites this paper
• t Requirement of Endogenous Basic Fibroblast Growth Factor for Sensitization to Amphetamine

  2000cites this paper
• Basic fibroblast growth factor as a mediator of the effects of glutamate in the development of long-lasting sensitization to stimulant drugs: studies in the rat

  2000cites this paper
• Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine.

  2000cites this paper
• Untersuchung der Plasmaoxidierbarkeit und des Antioxidantienstatus im Blutplasma von Patienten mit Morbus Parkinson: ein Beitrag zur Frage des oxidativen Streß in der Pathogenese des Morbus Parkinson

  2000cites this paper
• Metabolism and functions of glutathione in brain.

  2000cites this paper
• Glutathione metabolism in brain

  2000cites this paper
• Changes in astrocytic basic fibroblast growth factor expression during and after prolonged exposure to escalating doses of amphetamine.

  2000cites this paper
• Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species.

  2000cites this paper
• Induction of reactive astrocytosis and prevention of motoneuron cell death by the I2‐imidazoline receptor ligand LSL 60101

  2000cites this paper
• 6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism

  2000cites this paper
• Nitrite- and peroxide-dependent oxidation pathways of dopamine: 6-nitrodopamine and 6-hydroxydopamine formation as potential contributory mechanisms of oxidative stress- and nitric oxide-induced neurotoxicity in neuronal degeneration.

  1999cites this paper
• Glial Cells Mediate Toxicity in Glutathione‐Depleted Mesencephalic Cultures

  1999cites this paper
• Glial Cells Protect Neurons Against Oxidative Stress via Transcriptional Up‐Regulation of the Glutathione Synthesis

  1999cites this paper
• Excitotoxicity plays a role in the death of tyrosine hydroxylase- immunopositive nigral neurons cultured in serum-free medium.

  1999cites this paper
• Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro

  1999cites this paper
• The Antioxidative Effect of Carboxyfullerenes (C3/D3) on Iron‐Induced Oxidative Injury in CNS

  1999cites this paper
• Dexamethasone enhances serum deprivation-induced necrotic death of rat C6 glioma cells through activation of glucocorticoid receptors.

  1999cites this paper
• Immortalized dopamine neurons: A model to study neurotoxicity and neuroprotection.

  1999cites this paper
• Effect of basic fibroblast growth factor on focal ischemic injury and antioxidant enzyme activities.

  1999cites this paper
• Depletion of Intracellular Glutathione Increases Susceptibility to Nitric Oxide in Mesencephalic Dopaminergic Neurons

  1999cites this paper
• Carboxyfullerene Prevents Iron‐Induced Oxidative Stress in Rat Brain

  1999cites this paper
• Ovariectomy of Adult Rats Leads to Increased Expression of Astrocytic Basic Fibroblast Growth Factor in the Ventral Tegmental Area and in Dopaminergic Projection Regions of the Entorhinal and Prefrontal Cortex

  1999cites this paper
• Immortalized Dopamine Neurons: A Model To Study Neurotoxicity and Neuroprotection (44439)

  1999cites this paper
• The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity

  1999cites this paper
• Glial cell line derived neurotrophic factor promotes the recovery of dopamine neurons damaged by 6-hydroxydopamine in vitro

  1999cites this paper
• Role of Oxidative Stress and the Glutathione System in Loss of Dopamine Neurons Due to Impairment of Energy Metabolism

  1998cites this paper
• Acidic fibroblast growth factor rescues gerbil hippocampal neurons from ischemic apoptotic death.

  1998cites this paper
• Cell culture models of neuronal degeneration and neuroprotection. Implications for Parkinson's disease.

  1998cites this paper
• Immunohistochemical analyses of fibroblast growth factor receptor-1 in the human substantia nigra. Comparison between normal and Parkinson's disease cases.

  1998cites this paper
• Understanding cell death in parkinson's disease

  1998cites this paper
• Melatonin increases striatal dopaminergic function in 6‐OHDA‐lesioned rats

  1998cites this paper